Showing all publications

Pages

Daclatasvir plus peginterferon and ribavirin is noninferior to peginterferon and ribavirin alone, and reduces the duration of treatment for HCV genotype 2 or 3 infection.

Dore GJ; Lawitz E; Hézode C; Shafran SD; Ramji A; Tatum HA; Taliani G; Tran A; Brunetto MR; Zaltron S; Strasser SI; Weis N; Ghesquiere W; Lee SS; Larrey D; Pol S; Harley H; George J; Fung SK; de Lédinghen V; Hagens P; McPhee F; Hernandez D; Cohen D; Cooney E; Noviello S; Hughes EA.
, 2015.

Factors associated with hepatitis C virus RNA levels in early chronic infection: the InC(3) study.

Hajarizadeh B; Grady B; Page K; Kim AY; McGovern BH; Cox AL; Rice TM; Sacks-Davis R; Bruneau J; Morris M; Amin J; Schinkel J; Applegate T; Maher L; Hellard M; Lloyd AR; Prins M; Geskus RB; Dore GJ; Grebely J.
, 2015.

A new approach to estimating trends in chlamydia incidence.

Ali H; Cameron E; Drovandi CC; McCaw JM; Guy RJ; Middleton M; El-Hayek C; Hocking JS; Kaldor JM; Donovan B; Wilson DP.
, 2015.

Is it time to rethink syphilis control?

Boyd MA; Donovan B; Prestage G; Chen M; Petoumenos K; Gray R; Guy R; Rogers GB; Bourne C; Klausner JD.
, 2015.

Site-specific human papillomavirus infection in adolescent men who have sex with men (HYPER): an observational cohort study.

Zou H; Tabrizi SN; Grulich AE; Hocking JS; Bradshaw CS; Cornall AM; Morrow A; Prestage G; Law MG; Garland SM; Chen MY; Fairley CK.
, 2015.

Pages